Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse CancersAaron M. Goodman, Razelle Kurzrock, Shumei Kato et al.|Molecular Cancer Therapeutics|2017Cited by 2.4k
PD-L1 Expression as a Predictive Biomarker in Cancer ImmunotherapySandip Pravin Patel, Razelle Kurzrock|Molecular Cancer Therapeutics|2015Cited by 2.3k
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in OncologyDavid S. Ettinger, Miranda Hughes, Douglas E. Wood et al.|Journal of the National Comprehensive Cancer Network|2022Cited by 1.4k
RETRACTED ARTICLE: Microbiome analyses of blood and tissues suggest cancerdiagnostic approachGregory Poore, Rob Knight, Stefan Janssen et al.|Nature|2020Cited by 1k
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021David S. Ettinger, Miranda Hughes, Douglas E. Wood et al.|Journal of the National Comprehensive Cancer Network|2021Cited by 1k